The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level

J Thromb Haemost. 2005 May;3(5):1102-3. doi: 10.1111/j.1538-7836.2005.01312.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Blood Coagulation Tests
  • Case-Control Studies
  • Cross-Linking Reagents / pharmacology
  • Factor XIII / genetics*
  • Female
  • Fibrinogen / biosynthesis*
  • Fibrinogen / metabolism
  • Gene Frequency
  • Heterozygote
  • Homozygote
  • Humans
  • Leucine / chemistry
  • Male
  • Middle Aged
  • Mutation*
  • Odds Ratio
  • Risk
  • Valine / chemistry
  • Venous Thrombosis / genetics*
  • Venous Thrombosis / prevention & control*

Substances

  • Cross-Linking Reagents
  • Fibrinogen
  • Factor XIII
  • Leucine
  • Valine